The spin-off of the Josep Carreras Leukemia Research Institute, founded in 2015, develops a new class of drugs for the treatment of acute myeloid leukemia
The project seeks to foster public-private technology transfer in Catalonia and is part of the Ferrer R&D strategy to promote innovation through collaborations
Dr. Joan Bigorra, director of Innovation at the Hospital Clínic Barcelona
New knowledge regarding the genetic and molecular make-up of diseases and developments in information and imaging technology is changing the face of biomedical research.
Developed by Drauta